Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
400 CHF | +388.82% | -.--% | -.--% |
07-03 | Stocks to watch as Biden and Trump vie for presidency | RE |
07-01 | Merck, Orion Convert Ongoing Collaboration Into Exclusive Global License for Opevesostat | MT |
Official Publications
Dividends | CO | |
SEC Filing 4K | CO | |
SEC Filing 4K | CO | |
SEC Filing 4K | CO | |
SEC Filing 4K | CO | |
SEC Filing 4K | CO | |
SEC Filing 4K | CO | |
SEC Filing 10Q-1 | CO | |
Slide show Q1 | CO | |
1st quarter results | CO | |
SEC Filing 8K | CO | |
Proxy Statments | CO | |
Annual ESG Report | CO | |
SEC Filing 10K | CO | |
SEC Filing 4K | CO | |
SEC Filing 4K | CO | |
SEC Filing 13G | CO | |
SEC Filing 8K | CO | |
Slide show results | CO | |
Annual results | CO | |
SEC Filing 8K | CO | |
Dividends | CO | |
Slide show Q3 | CO | |
3rd quarter results | CO | |
SEC Filing 8K | CO |
- Stock Market
- Equities
- MRK Stock
- MRK Stock
- News Merck & Co., Inc.
- Official Publications